Breaking Medical Technology
News: Aethlon Medical (NASDAQ: $AEMD) to Present at the Life Sciences Investor
Forum September 19th
Company invites
individual and institutional investors, as well as advisors and analysts, to
attend online at VirtualInvestorConferences.com
SAN
DIEGO, CA - September 13, 2024 (Investorideas.com Newswire) Aethlon Medical,
Inc. (Nasdaq: AEMD), a medical therapeutic company focused on
developing products to treat cancer and life-threatening infectious diseases,
is pleased to announce that Jim Frakes, interim CEO and CFO and Steve LaRosa,
Chief Medical Officer, will present live at the Life Sciences Investor Forum,
hosted by VirtualInvestorConferences.com, on September 19th 2024.
DATE: September 19th
TIME: 1:30 PM ET
LINK: https://bit.ly/3XjDJkL
Available for 1x1 meetings: September
19 and 20.
Paid News Dissemination of behalf of AEMD.
Read
this news featuring AEMD in full at https://www.investorideas.com/news/2024/09131AEMD-Present-at-the-Life-Sciences-Investor-Forum.asp
This will be a live, interactive
online event where investors are invited to ask the company questions in
real-time. If attendees are not able to join the event live on the day of the
conference, an archived webcast will also be made available after the event.
It is recommended that online
investors pre-register and run the online system check to expedite
participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
About Aethlon and the Hemopurifier®
Aethlon Medical is a medical
therapeutic company focused on developing the Hemopurifier, a clinical stage
immunotherapeutic device which is designed to combat cancer and
life-threatening viral infections and for use in organ transplantation. In
human studies, the Hemopurifier has demonstrated the removal of
life-threatening viruses and in pre-clinical studies, the Hemopurifier has
demonstrated the removal of harmful exosomes from biological fluids, utilizing
its proprietary lectin-based technology. This action has potential applications
in cancer, where exosomes may promote immune suppression and metastasis, and in
life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug
Administration (FDA) designated Breakthrough Device indicated for the treatment
of individuals with advanced or metastatic cancer who are either unresponsive
to or intolerant of standard of care therapy, and with cancer types in which
exosomes have been shown to participate in the development or severity of the
disease. The Hemopurifier also holds an FDA Breakthrough Device designation and
an open Investigational Device Exemption (IDE) application related to the
treatment of life-threatening viruses that are not addressed with approved
therapies.
Additional information can be found
at www.AethlonMedical.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is
the leading proprietary investor conference series that provides an interactive
forum for publicly traded companies to seamlessly present directly to
investors.
Providing a real-time investor
engagement solution, VIC is specifically designed to offer companies more
efficient investor access. Replicating the components of an on-site investor
conference, VIC offers companies enhanced capabilities to connect with
investors, schedule targeted one-on-one meetings and enhance their
presentations with dynamic video content. Accelerating the next level of
investor engagement, Virtual Investor Conferences delivers leading investor
communications to a global network of retail and institutional investors.
Company Contact:
Jim Frakes
Interim Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
Jfrakes@aethlonmedical.com
Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com
917-513-5303
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
SOURCE Aethlon Medical, Inc
Aethlon
Medical Inc. (Nasdaq:AEMD) is a featured biotech stock on Investorideas.com
More info on AEMD at Investorideas.com Visit: https://www.investorideas.com/CO/AEMD/
Get News
Alerts on Aethlon Medical
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced
news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. Contact management and IR of
each company directly regarding specific questions. Disclosure: Aethlon
Medical, Inc. (NASDAQ:AEMD) is a paid featured stock on Investorideas.com More
disclaimer info: https://www.investorideas.com/About/News/Clientspecifics.asp https://www.investorideas.com/About/Disclaimer.asp
Learn more about publishing your news release and
our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of
each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Biotech Industry Stocks- investing ideas
in biotechnology stocks, medical technology and life sciences
No comments:
Post a Comment